Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03435484
Other study ID # RCT PHA Optimization
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 7, 2018
Est. completion date May 31, 2019

Study information

Verified date October 2022
Source NYU Langone Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed study aims to examine several iterations of instructions/reminders that patients receive for completing the Health Assessment Questionnaire (self-reported health outcomes) for their outpatient visit at NYU Langone Orthopedic Center. The goal is to increase the completion rates of patient-reported health outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 27263
Est. completion date May 31, 2019
Est. primary completion date May 31, 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - All patients who are eligible to receive the Health Assessment Questionnaire in preparation for and during their outpatient visit to the NYU Langone Orthopedic Center. Exclusion Criteria: - N/A

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Arm A
Intervention includes various iterations of instructions for completing the Health Assessment Questionnaire. Participants in this group will receive one version (out of two) of instructions for completing the Health Assessment Questionnaire.
Arm B
Intervention includes various iterations of instructions for completing the Health Assessment Questionnaire. Participants in this group will receive another version (out of two) of instructions for completing the Health Assessment Questionnaire.

Locations

Country Name City State
United States New York University School of Medicine New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Questionnaire Completion Rate (number of times patients complete or partially complete the questionnaire). Completion rate data is routinely collected by the medical center. Duration of the study, up to 6 months.
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06012318 - Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)
Recruiting NCT05596890 - Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients Phase 2
Completed NCT03341377 - Perioperative Symptom Study of Lung Cancer (CN-PRO-Lung 1)
Recruiting NCT05841186 - Correlation of Timing of Pegfilgrastim Administration and PIBP. N/A